BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28760202)

  • 1. High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease.
    Sara JDS; Prasad M; Zhang M; Lennon RJ; Herrmann J; Lerman LO; Lerman A
    Am Heart J; 2017 Aug; 190():1-11. PubMed ID: 28760202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction.
    El Sabbagh A; Prasad M; Zack CJ; Widmer RJ; Karon BS; Lerman A; Jaffe AS
    J Invasive Cardiol; 2018 Nov; 30(11):406-410. PubMed ID: 30373950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects.
    Hasdai D; Gibbons RJ; Holmes DR; Higano ST; Lerman A
    Circulation; 1997 Nov; 96(10):3390-5. PubMed ID: 9396432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma.
    Dhawan SS; Corban MT; Nanjundappa RA; Eshtehardi P; McDaniel MC; Kwarteng CA; Samady H
    Atherosclerosis; 2012 Aug; 223(2):384-8. PubMed ID: 22766333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.
    Prasad M; Matteson EL; Herrmann J; Gulati R; Rihal CS; Lerman LO; Lerman A
    Hypertension; 2017 Feb; 69(2):236-242. PubMed ID: 27993955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: findings from the TweeSteden Mild Stenosis Study (TWIST).
    Mommersteeg PM; Meeuwis SH; Denollet J; Widdershoven JW; Aarnoudse W; Westerhuis BL; Kop WJ
    J Psychosom Res; 2014 Nov; 77(5):426-9. PubMed ID: 25307791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
    Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
    Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography.
    Seo WW; Kim HL; Kim YJ; Yoon YE; Lee SP; Kim HK; Cho GY; Zo JH; Choi DJ; Sohn DW
    J Cardiol; 2016 Sep; 68(3):222-8. PubMed ID: 26481470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
    Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
    Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.